GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 117 filers reported holding GENERATION BIO CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,368,902 | -33.3% | 485,396 | -3.7% | 0.00% | -100.0% |
| Q1 2024 | $2,052,301 | +82.0% | 504,251 | -26.2% | 0.00% | – |
| Q4 2023 | $1,127,599 | -60.9% | 683,100 | -10.3% | 0.00% | -100.0% |
| Q3 2023 | $2,885,721 | -18.6% | 761,419 | +18.1% | 0.00% | 0.0% |
| Q2 2023 | $3,543,387 | +51.2% | 644,500 | +18.3% | 0.00% | 0.0% |
| Q1 2023 | $2,342,977 | +131676.0% | 544,835 | +20.4% | 0.00% | 0.0% |
| Q4 2022 | $1,778 | -99.9% | 452,460 | +35.9% | 0.00% | 0.0% |
| Q3 2022 | $1,768,000 | +110.0% | 332,973 | +159.8% | 0.00% | – |
| Q2 2022 | $842,000 | -8.0% | 128,141 | +2.7% | 0.00% | – |
| Q1 2022 | $915,000 | -2.1% | 124,736 | -5.6% | 0.00% | – |
| Q4 2021 | $935,000 | -36.6% | 132,128 | +124.5% | 0.00% | – |
| Q3 2021 | $1,475,000 | – | 58,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $35,601,781 | 4.82% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,396,909 | 0.86% |
| Artal Group S.A. | 2,814,191 | $12,101 | 0.72% |
| PFM Health Sciences, LP | 2,648,297 | $11,387,677 | 0.50% |
| SVB FINANCIAL GROUP | 40,401 | $173,724 | 0.33% |
| SECTORAL ASSET MANAGEMENT INC | 385,070 | $1,655,801 | 0.32% |
| Yiheng Capital Management, L.P. | 1,601,766 | $6,887,594 | 0.27% |
| EcoR1 Capital, LLC | 1,956,579 | $8,413,290 | 0.27% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,194,522 | 0.23% |
| Bellevue Group AG | 3,620,280 | $15,567,204 | 0.23% |